Siciliano G, Piazza S, Carlesi C, Del Corona A, Franzini M, Pompella A, Malvaldi G, Mancuso M, Paolicchi A, Murri L
Dept. of Neuroscience Neurological clinic, University of Pisa, Via Roma 67, 56126, Pisa, Italy.
J Neurol. 2007 May;254(5):575-80. doi: 10.1007/s00415-006-0301-1. Epub 2007 Apr 11.
The causes of Amyotrophic Lateral Sclerosis (ALS) are unknown. A bulk of evidence supports the hypothesis that oxidative stress and mitochondrial dysfunction can be implicated in ALS pathogenesis. METHODS =: We assessed, in cerebrospinal fluid (CSF) and in plasma of 49 ALS patients and 8 controls, the amount of oxidized proteins (AOPP, advanced oxidation protein products), the total antioxidant capacity (FRA, the ferric reducing ability), and, in CSF, two oxidation products, the 4-hydroxynonenal and the sum of nitrites plus nitrates.
The FRA was decreased (p = 0.003) in CSF, and AOPP were increased in both CSF (p = 0.0039) and plasma (p = 0.001) of ALS patients. The content of AOPP was differently represented in CSF of ALS clinical subsets, resulting in increase in the common and pseudopolyneuropathic forms (p < 0.001) and nearly undetectable in the bulbar form, as in controls. The sum of nitrites plus nitrates and 4-hydroxynonenal were unchanged in ALS patients compared with controls.
Our results, while confirming the occurrence of oxidative stress in ALS, indicate how its effects can be stratified and therefore implicated differently in the pathogenesis of different clinical forms of ALS.
肌萎缩侧索硬化症(ALS)的病因尚不清楚。大量证据支持氧化应激和线粒体功能障碍可能与ALS发病机制有关的假说。方法:我们评估了49例ALS患者和8例对照者脑脊液(CSF)和血浆中氧化蛋白(AOPP,晚期氧化蛋白产物)的含量、总抗氧化能力(FRA,铁还原能力),以及脑脊液中两种氧化产物4-羟基壬烯醛和亚硝酸盐与硝酸盐之和。
ALS患者脑脊液中的FRA降低(p = 0.003),脑脊液(p = 0.0039)和血浆(p = 0.001)中的AOPP均升高。AOPP的含量在ALS临床亚组的脑脊液中有不同表现,在常见型和假多神经病型中升高(p < 0.001),在延髓型中几乎检测不到,与对照组一样。与对照组相比,ALS患者亚硝酸盐与硝酸盐之和及4-羟基壬烯醛无变化。
我们的结果在证实ALS中存在氧化应激的同时,表明其影响如何分层,因此在不同临床类型的ALS发病机制中的作用也不同。